Qiagen NV QGEN Stock Analysis
- NYSE
- Stock
- Market closed · opens Monday 9:30 AM ET
$50.33 down $0.53, 1.04% at close Nov 6
Last close · Previous close $50.86
- Market cap
- $10.41BAt the Nov 6 close
- P/E ratio
- 26.08On last 12 months’ EPS
- Diluted EPS
- $1.93Last 12 months
- Dividend yield
- 5.25%Last 12 months
Price chart
$50.33down $0.53, 1.04%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$50.86Nov 5
- Volume3.39MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume5.92MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $32.53 to $57.82; now $50.33
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
QGEN beat the S&P 500 in 4 of 7 periods.
| Period | QGEN and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | QGEN: up 10.3% S&P 500: down 5.6% | QGEN beat the S&P 500 by 15.9 percentage points Beat |
| 3M | QGEN: up 20.6% S&P 500: down 4.1% | QGEN beat the S&P 500 by 24.7 percentage points Beat |
| YTD | QGEN: up 12.4% S&P 500: up 8.7% | QGEN beat the S&P 500 by 3.7 percentage points Beat |
| 1Y | QGEN: up 17.3% S&P 500: up 10.9% | QGEN beat the S&P 500 by 6.4 percentage points Beat |
| Long term | ||
| 3Y | QGEN: up 30.2% S&P 500: up 75.0% +9.2% vs +20.5% a year | QGEN trailed the S&P 500 by 44.8 percentage points Trailed |
| 5Y | QGEN: down 6.5% S&P 500: up 67.8% −1.3% vs +10.9% a year | QGEN trailed the S&P 500 by 74.3 percentage points Trailed |
| 10Y | QGEN: up 90.4% S&P 500: up 313.1% +6.7% vs +15.2% a year | QGEN trailed the S&P 500 by 222.7 percentage points Trailed |
$10,000 invested in QGEN 10 years ago (Nov 4, 2016) would be worth about $19,042 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
QGEN beat the S&P 500 in 3 of 7 periods.
| Period | QGEN and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | QGEN: up 10.3% S&P 500: down 5.6% | QGEN beat the S&P 500 by 15.9 percentage points Beat |
| 3M | QGEN: up 20.6% S&P 500: down 4.3% | QGEN beat the S&P 500 by 24.9 percentage points Beat |
| YTD | QGEN: up 6.3% S&P 500: up 7.8% | QGEN trailed the S&P 500 by 1.5 percentage points Trailed |
| 1Y | QGEN: up 11.0% S&P 500: up 9.7% | QGEN beat the S&P 500 by 1.3 percentage points Beat |
| Long term | ||
| 3Y | QGEN: up 19.0% S&P 500: up 68.8% +6.0% vs +19.1% a year | QGEN trailed the S&P 500 by 49.8 percentage points Trailed |
| 5Y | QGEN: down 14.6% S&P 500: up 56.9% −3.1% vs +9.4% a year | QGEN trailed the S&P 500 by 71.5 percentage points Trailed |
| 10Y | QGEN: up 67.7% S&P 500: up 252.6% +5.3% vs +13.4% a year | QGEN trailed the S&P 500 by 184.9 percentage points Trailed |
$10,000 invested in QGEN 10 years ago (Nov 4, 2016) would be worth about $16,773 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$64.73
Closing high on . Now 22.2% below that record.
Split-adjusted daily closes since Jun 28, 1996.
Stock splits
5
Latest: 1-for-1.05 on . One share bought before the first split is 8 shares today.
All 5 splits
- 1-for-1.05
- 1-for-1.03
- 1-for-1.04
- 4-for-1
- 2-for-1
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
26.1×The Nov 6 close ÷ diluted EPS over the last 12 months ($1.93)
The range covers daily P/E ratios from Oct 28, 2021 to Nov 6, 2026, each based on the previous 12 months of earnings.
QGEN trades at 26.1× its earnings over the last 12 months, below its 5-year median of 28.0×. In plain terms, buyers are paying about $26 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 5.0×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 3.1×Book value as of Jun 30, 2026
Price relative to accounting equity (book value) per share on the Jun 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - 16.0×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 1.93Last 12 months’ EPS growth
The P/E divided by the growth in diluted EPS over the last 12 months (+13.5% on the 12 months before). It looks backward: near 1 means the P/E roughly matches last year’s growth. Sites that use analysts’ growth forecasts show a different PEG.
PEG = P/E ÷ EPS growth (%) = 26.1 ÷ 13.5 - 4.30%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $11.26BAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Jun 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own QGEN DCF in Excel. Value Qiagen NV with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $2.10Bup 3.0%
- Net income
- $409.32Mup 9.6%
- Diluted EPS
- $1.93up 13.5%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $501.87M | $98.06M | $0.44 |
| Q4 FY24 (Dec 31, 2024) | $521.20M | $88.32M | $0.40 |
| Q1 FY25 (Mar 31, 2025) | $483.46M | $90.76M | $0.42 |
| Q2 FY25 (Jun 30, 2025) | $533.54M | $96.25M | $0.44 |
| Q3 FY25 (Sep 30, 2025) | $532.58M | $130.04M | $0.60 |
| Q4 FY25 (Dec 31, 2025) | $540.42M | $107.83M | $0.50 |
| Q1 FY26 (Mar 31, 2026) | $492.32M | $68.04M | $0.33 |
| Q2 FY26 (Jun 30, 2026) | $535.04M | $103.40M | $0.50 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $2.25B | $512.60M | $2.25 |
| FY22 (Dec 31, 2022) | $2.14B | $423.21M | $1.86 |
| FY23 (Dec 31, 2023) | $1.97B | $341.30M | $1.50 |
| FY24 (Dec 31, 2024) | $1.98B | $83.59M | $0.38 |
| FY25 (Dec 31, 2025) | $2.09B | $424.88M | $1.96 |
Margins
- Gross 62.2%
- Operating 21.2%
- Net 19.5%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $447.70MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$654.47MLast 12 months
- Capital spending$206.77MLast 12 months
- 21.3%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $496.75MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paidNot reportedLast 12 months
Balance sheet
- $793.50MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$1.64BAs of Jun 30, 2026
- Net debt$850.12MAs of Jun 30, 2026
- 2.85As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.49As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 6 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✓Return on assets improved: passed
- ✓Operating cash flow exceeded net income: passed
- ✗Long-term debt fell relative to assets: not passed
- ✓Current ratio improved: passed
- ✓Share count didn’t rise: passed
- ✗Gross margin improved: not passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- 11.6%Last 12 months
Over the last 12 months, Qiagen NV’s net income was 11.6% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 6.7%Last 12 months
Over the last 12 months, Qiagen NV’s net income was 6.7% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.000 |
| 2017 | $1.13 |
| 2018 | $0.000 |
| 2019 | $0.000 |
| 2020 | $0.000 |
| 2021 | $0.000 |
| 2022 | $0.000 |
| 2023 | $0.000 |
| 2024 | $1.39 |
| 2025 | $0.26 |
| 2026 (to date) | $2.64 |
Dividend details
- $2.64Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- 5.25%; 5-yr low 0.48%, 5-yr high 7.78%Last 12 months
Dividends paid over the last 12 months as a share of the Nov 6 close. The bar shows where that yield sits in its range over the past five years; the median was 2.34%.
- $0.35Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencySemiannual2 payments in the last 12 months
- 136.8%Last 12 months
The share of earnings paid out as dividends over the last 12 months. Lower ratios leave more room to reinvest or raise the dividend.
Payout = Dividends per share ÷ Diluted EPS (both last 12 months)Payout ratio calculator
About Qiagen NV
QIAGEN N.V., (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated instrumentation systems provides customers to transform raw biological samples into valuable molecular information.The Company serves four customer classes: Molecular Diagnostics laboratories; Applied Testing customers in fields such as forensics, veterinary diagnostics and food safety; Pharmaceutical research and development groups, and Academic researchers. The Company market its products in more than 100 countries. The Company offers more than 500 core consumable products as well as a number of instrument solutions to automate the processing of almost all QIAGEN products used for sample preparation and subsequent analysis. On May 3, 2012, the Company acquired AmniSure International LLC.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Netherlands
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- NYSE
- Asset type
- Common stock
- Price history since
QGEN news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
QGEN stock FAQ
What is QGEN stock’s price today?
Qiagen NV (QGEN) traded at $50.33 at the close on , down $0.53 (1.04%) from the previous close of $50.86. Over the past 52 weeks it has traded between $32.53 and $57.82.
If you invested $1,000 in QGEN 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in QGEN on would be worth about $1,904 at the close on , a total return of +90.4%. The same $1,000 would be worth $935 if invested five years ago, $1,173 if invested one year ago, $3,208 if invested 20 years ago, and $15,437 if invested 30 years ago. Past performance doesn’t predict future returns.
What is Qiagen NV’s market cap?
Qiagen NV’s market capitalization is about $10.4 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $50.33 (how market cap works). Qiagen NV reported 206.80M shares outstanding at the end of its latest quarter ().
What is QGEN’s P/E ratio?
QGEN trades at 26.1 times its diluted earnings over the four quarters to ($1.93 per share), at the close. Over the past five years its P/E has ranged from 17.6 to 152.6, with a median of 27.9. (How the P/E ratio works.)
How much revenue does Qiagen NV make?
Qiagen NV reported $2.1 billion of revenue over the four quarters to , up 3.0% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $535.0 million, up 0.3% from a year earlier.
Is Qiagen NV profitable?
Yes. Qiagen NV earned $409.3 million of net income over the four quarters to , a net margin of 19.5%, and its operating margin was 21.2% (what margins tell you).
What are QGEN’s earnings per share?
QGEN’s diluted earnings per share were $1.93 over the four quarters to , compared with $1.70 in the twelve months before. The latest quarter (Q2 FY26) brought $0.50 per share, against $0.44 a year earlier (how EPS works).
Does QGEN pay a dividend?
Yes. Qiagen NV pays a semiannual dividend. The most recent was $0.35 per share, with an ex-dividend date of . Over the last twelve months it paid $2.64 per share, a 5.25% yield at the close (how dividend yield works).
Based on the last 12 months’ payments ($2.64 per share), and if the next 12 months match the last 12, 100 shares would receive about $264 over 12 months, and $1,000 over 12 months would take about 379 shares, roughly $19,075 at the close. Dividends can change.
What is QGEN’s 52-week high and low?
Over the past 52 weeks QGEN has traded as low as $32.53 and as high as $57.82. At $50.33 at the close on , it is 12.9% below that high and 54.7% above the low.
What is QGEN’s all-time high?
QGEN’s highest closing price was $64.73 on , adjusted for stock splits. At $50.33 at the close on , it is 22.2% below that record.
Has QGEN stock ever split?
Yes, five times: 2-for-1 on ; 4-for-1 on ; 1-for-1.04 on ; 1-for-1.03 on ; 1-for-1.05 on . One share bought before the first split would be 8 shares today.
How has QGEN stock performed?
Including dividends and measured to the close on , QGEN has returned +12.4% so far this year and +17.3% over the past year, and −6.5% over five years (−1.3% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Qiagen NV in?
Qiagen NV is in the Healthcare sector and the Diagnostics & Research industry, and is headquartered in Netherlands.
What exchange does QGEN trade on?
Qiagen NV trades on the NYSE under the ticker symbol QGEN. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.